The Worldwide Economic Impact of Neurogenic Bladder

Chandra Flack, Charles Powell

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Costs of neurogenic bladder vary widely and depend on a number of factors including severity of disease, symptomatology, patient insurance, and devices required. Recognition of how each treatment strategy will impact the patient financially could help guide selection of treatment as well as improve compliance with the chosen regimen. We have attempted to provide an overview of long-term cost considerations for the neurogenic bladder patient. Armed with this information, the practitioner can better help the patient select a bladder care regimen that balances the desire to both minimize symptoms now and preserve urinary tract integrity for the future, yet still remain cost-effective.

Original languageEnglish (US)
Pages (from-to)350-354
Number of pages5
JournalCurrent Bladder Dysfunction Reports
Volume10
Issue number4
DOIs
StatePublished - Dec 1 2015

Fingerprint

Neurogenic Urinary Bladder
Economics
Costs and Cost Analysis
Costs
Insurance
Urinary Tract
Urinary Bladder
Equipment and Supplies
Therapeutics

Keywords

  • Costs and cost analysis
  • Health expenditures
  • Incontinence pads
  • Intermittent urethral catheterization
  • Urinary bladder—neurogenic
  • Urinary bladder—overactive
  • Urinary incontinence
  • Urinary retention

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Cite this

The Worldwide Economic Impact of Neurogenic Bladder. / Flack, Chandra; Powell, Charles.

In: Current Bladder Dysfunction Reports, Vol. 10, No. 4, 01.12.2015, p. 350-354.

Research output: Contribution to journalArticle

@article{f2d1dbd38ce749ee8ae91181b669151e,
title = "The Worldwide Economic Impact of Neurogenic Bladder",
abstract = "Costs of neurogenic bladder vary widely and depend on a number of factors including severity of disease, symptomatology, patient insurance, and devices required. Recognition of how each treatment strategy will impact the patient financially could help guide selection of treatment as well as improve compliance with the chosen regimen. We have attempted to provide an overview of long-term cost considerations for the neurogenic bladder patient. Armed with this information, the practitioner can better help the patient select a bladder care regimen that balances the desire to both minimize symptoms now and preserve urinary tract integrity for the future, yet still remain cost-effective.",
keywords = "Costs and cost analysis, Health expenditures, Incontinence pads, Intermittent urethral catheterization, Urinary bladder—neurogenic, Urinary bladder—overactive, Urinary incontinence, Urinary retention",
author = "Chandra Flack and Charles Powell",
year = "2015",
month = "12",
day = "1",
doi = "10.1007/s11884-015-0323-6",
language = "English (US)",
volume = "10",
pages = "350--354",
journal = "Current Bladder Dysfunction Reports",
issn = "1931-7212",
publisher = "Current Medicine Group",
number = "4",

}

TY - JOUR

T1 - The Worldwide Economic Impact of Neurogenic Bladder

AU - Flack, Chandra

AU - Powell, Charles

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Costs of neurogenic bladder vary widely and depend on a number of factors including severity of disease, symptomatology, patient insurance, and devices required. Recognition of how each treatment strategy will impact the patient financially could help guide selection of treatment as well as improve compliance with the chosen regimen. We have attempted to provide an overview of long-term cost considerations for the neurogenic bladder patient. Armed with this information, the practitioner can better help the patient select a bladder care regimen that balances the desire to both minimize symptoms now and preserve urinary tract integrity for the future, yet still remain cost-effective.

AB - Costs of neurogenic bladder vary widely and depend on a number of factors including severity of disease, symptomatology, patient insurance, and devices required. Recognition of how each treatment strategy will impact the patient financially could help guide selection of treatment as well as improve compliance with the chosen regimen. We have attempted to provide an overview of long-term cost considerations for the neurogenic bladder patient. Armed with this information, the practitioner can better help the patient select a bladder care regimen that balances the desire to both minimize symptoms now and preserve urinary tract integrity for the future, yet still remain cost-effective.

KW - Costs and cost analysis

KW - Health expenditures

KW - Incontinence pads

KW - Intermittent urethral catheterization

KW - Urinary bladder—neurogenic

KW - Urinary bladder—overactive

KW - Urinary incontinence

KW - Urinary retention

UR - http://www.scopus.com/inward/record.url?scp=84946045662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946045662&partnerID=8YFLogxK

U2 - 10.1007/s11884-015-0323-6

DO - 10.1007/s11884-015-0323-6

M3 - Article

AN - SCOPUS:84946045662

VL - 10

SP - 350

EP - 354

JO - Current Bladder Dysfunction Reports

JF - Current Bladder Dysfunction Reports

SN - 1931-7212

IS - 4

ER -